Literature DB >> 27742443

Functional exosome-mimic for delivery of siRNA to cancer: in vitro and in vivo evaluation.

Zhaogang Yang1, Jing Xie2, Jing Zhu3, Chen Kang3, Chiling Chiang4, Xinmei Wang1, Xiaobing Wang5, Tairong Kuang1, Feng Chen1, Zhou Chen1, Aili Zhang1, Bo Yu1, Robert J Lee3, Lesheng Teng6, L James Lee7.   

Abstract

Exosomes, the smallest subgroup of extracellular vesicles, have been recognized as extracellular organelles that contain genetic and proteomic information for long distance intercellular communication. Exosome-based drug delivery is currently a subject of intensive research. Here, we report a novel strategy to produce nanoscale exosome-mimics (EMs) in sufficient quantity for gene delivery in cancer both in vitro and in vivo. Size-controllable EMs were generated at a high yield by serial extrusion of non-tumorigenic epithelial MCF-10A cells through filters with different pore sizes. siRNA was then encapsulated into the EMs by electroporation. Biosafety and uptake efficiency of the EMs were evaluated both in vitro and in vivo. The mechanism underlying their cellular endocytosis was also studied.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Electroporation; Endocytosis; Exosome; MCF-7; siRNA

Mesh:

Substances:

Year:  2016        PMID: 27742443     DOI: 10.1016/j.jconrel.2016.10.008

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  35 in total

Review 1.  Therapeutically harnessing extracellular vesicles.

Authors:  Lesley Cheng; Andrew F Hill
Journal:  Nat Rev Drug Discov       Date:  2022-03-02       Impact factor: 84.694

2.  Optimized Protocol for Plasma-Derived Extracellular Vesicles Loading with Synthetic miRNA Mimic Using Electroporation.

Authors:  Margherita A C Pomatto; Federica Negro; Giovanni Camussi
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Recent Advancement and Technical Challenges in Developing Small Extracellular Vesicles for Cancer Drug Delivery.

Authors:  Tianjiao Geng; Patrick Pan; Euphemia Leung; Qi Chen; Larry Chamley; Zimei Wu
Journal:  Pharm Res       Date:  2021-02-18       Impact factor: 4.200

Review 4.  Exosomes in diagnosis and therapy of prostate cancer.

Authors:  Jun Pan; Meng Ding; Kai Xu; Chunhua Yang; Li-Jun Mao
Journal:  Oncotarget       Date:  2017-06-17

5.  Microfluidic hydrodynamic focusing synthesis of polymer-lipid nanoparticles for siRNA delivery.

Authors:  Xueqin Huang; Robert J Lee; Yuhang Qi; Yujing Li; Jiahui Lu; Qingfan Meng; Lesheng Teng; Jing Xie
Journal:  Oncotarget       Date:  2017-05-30

6.  The Synergistic Effect of Microwave Radiation and Hypergravity on Rats and the Intervention Effect of Rana Sylvatica Le Conte Oil.

Authors:  Wei Sun; Yudan Yang; Hongmei Yu; Luowei Wang; Su Pan
Journal:  Dose Response       Date:  2017-06-30       Impact factor: 2.658

7.  Evaluation of antitumor activity of survivin short interfering RNA delivered by lipid nanoparticles in colon cancer in vitro and in vivo.

Authors:  Tianyou Wang; Ziqin Liu; Zhaoxia Zhang; Suoqin Tang; Mei Yue; Shunqiao Feng; Mengze Hu; Litian Xuan; Yanfei Chen
Journal:  Oncol Lett       Date:  2017-06-16       Impact factor: 2.967

8.  Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells.

Authors:  Xiaohua Zhu; Mohamed Badawi; Steven Pomeroy; Dhruvitkumar S Sutaria; Zhiliang Xie; Alice Baek; Jinmai Jiang; Ola A Elgamal; Xiaokui Mo; Krista La Perle; Jeffrey Chalmers; Thomas D Schmittgen; Mitch A Phelps
Journal:  J Extracell Vesicles       Date:  2017-06-06

9.  A novel release kinetics evaluation of Chinese compound medicine: Application of the xCELLigence RTCA system to determine the release characteristics of Sedum sarmentosum compound sustained-release pellets.

Authors:  Guojun Yan; Wei Sun; Yanfang Pei; Zhaogang Yang; Xiaobing Wang; Yuan Sun; Shangtian Yang; Jinhuo Pan
Journal:  Saudi Pharm J       Date:  2017-07-19       Impact factor: 4.330

10.  Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer.

Authors:  Qiumo Zhang; Haiyang Zhang; Tao Ning; Dongying Liu; Ting Deng; Rui Liu; Ming Bai; Kegan Zhu; Jialu Li; Qian Fan; Guoguang Ying; Yi Ba
Journal:  Int J Nanomedicine       Date:  2020-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.